By The Hill |
December 10, 2019
Entrepreneur Andrew Yang on Tuesday released a plan to lower prescription drug costs, which includes allowing Medicare to negotiate drug prices and creating public manufacturing facilities to make generic drugs.
Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders.
One of the most important elements of a company’s success is also one of the least tangible —culture.